HCV‐specific T cells in HCV/HIV co‐infection show elevated frequencies of dual Tim‐3/PD‐1 expression that correlate with liver disease progression

Co‐infection of HCV with HIV has been associated with more rapid progression of HCV‐related disease. HCV‐specific T‐cell immune responses, which are essential for disease control, are attenuated in co‐infection with HIV. T‐cell exhaustion has recently been implicated in the deficient control of chronic viral infections. In the current study, we investigated the role of programmed death‐1 (PD‐1) and T‐cell immunoglobulin and mucin domain‐containing molecule‐3 (Tim‐3) expression in T‐cell exhaustion during HCV/HIV co‐infection. We show that in HCV/HIV co‐infection, both total and HCV‐specific T cells co‐express Tim‐3 and PD‐1 in significantly higher frequencies, compared with HCV mono‐infection. Co‐expression of these two markers on HCV‐specific CD8+ T cells positively correlated with a clinical parameter of liver disease progression. HCV‐specific CD8+ T cells showed greater frequencies of Tim‐3/PD‐1 co‐expression than HIV‐specific CD8+ T cells, which may indicate a greater degree of exhaustion in the former. Blocking Tim‐3 or PD‐1 pathways restored both HIV‐ and HCV‐specific CD8+ T‐cell expansion in the blood of co‐infected individuals. These data demonstrate that co‐expression of Tim‐3 and PD‐1 may play a significant role in HCV‐specific T‐cell dysfunction, especially in the setting of HIV co‐infection.

[1]  T. Heeren,et al.  Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection , 2010, The American Journal of Gastroenterology.

[2]  R. Sterling,et al.  Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C , 2009, Alimentary pharmacology & therapeutics.

[3]  R. Koup,et al.  Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection1 , 2009, The Journal of Immunology.

[4]  B. McMahon,et al.  Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells , 2009, Journal of Virology.

[5]  G. Freeman,et al.  Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade , 2009, PLoS pathogens.

[6]  R. Kaul,et al.  Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection , 2008, The Journal of experimental medicine.

[7]  R. Kaul,et al.  HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection , 2008, PloS one.

[8]  R. Kaul,et al.  Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. , 2008, The Journal of infectious diseases.

[9]  N. Afdhal,et al.  Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.

[10]  Todd M. Allen,et al.  Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells , 2008, PLoS medicine.

[11]  T. Wilson,et al.  The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients , 2007, AIDS.

[12]  Todd M. Allen,et al.  Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection , 2006, PLoS medicine.

[13]  R. Koup,et al.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.

[14]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[15]  M. Massari,et al.  PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion , 2006, Journal of Virology.

[16]  C. Cooper,et al.  Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus‐coinfected patients , 2005, HIV medicine.

[17]  C. Walker,et al.  Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.

[18]  R. Khanna,et al.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. , 2004, The Lancet. Infectious diseases.

[19]  C. Walker,et al.  Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.

[20]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[21]  J. Ghrayeb,et al.  Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection , 2003, The Journal of experimental medicine.

[22]  J. Hoofnagle,et al.  Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.

[23]  M. Lederman,et al.  HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens , 2002, AIDS.

[24]  E. Rosenberg,et al.  Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses , 2002, Journal of Virology.

[25]  J. Lieberman,et al.  Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. , 2000, Blood.

[26]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[27]  P. Schmid,et al.  Patients co‐infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA , 1999, Journal of viral hepatitis.

[28]  J. Altman,et al.  Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.

[29]  D. Vlahov,et al.  Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. , 1996, The Journal of infectious diseases.

[30]  M. Urdea,et al.  Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections , 1993, Journal of clinical microbiology.

[31]  E. Strauss,et al.  Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. , 2009, Annals of hepatology.

[32]  C. Soderberg-Naucler Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. , 2006, Critical reviews in immunology.

[33]  J. Lieberman,et al.  Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. , 2003, Blood.